District Tuberculosis Centre, Manjeri, Malappuram District, Kerala, India.
PLoS One. 2013 Oct 14;8(10):e76275. doi: 10.1371/journal.pone.0076275. eCollection 2013.
Kerala State, India has reported the greatest dual burden of Tuberculosis (TB) and Diabetes Mellitus (DM). Malappuram district in Kerala has monitored and recorded DM status and its control from 2010 under Revised National Tuberculosis Control Program (RNTCP).
To assess, under programme conditions, comprehensiveness of recording DM status among TB cases and the TB treatment outcomes among DM patients (disaggregated by glycemic control) and compare with-non DM patients.
This retrospective record review included 3,116TB patients from April 2010 to September 2011.DM was defined as per international guidelines and TB treatment outcomes were categorized as favourable(cured and treatment completed) and unfavourable(death, default, failure and transfer out). Relative Risk (RR) and 95% confidence intervals(CI) were calculated to assess the risk of unfavourable outcomes.
DM status was recorded in 90% of TB cases and 667 (24%) had DM. 17% of DM patients and 23% of patients with unknown DM status had unfavourable outcomes but this difference was not statistically significant. Unadjusted RR for poor glycemic control or unknown control status for unfavourable outcome were (2.00; 95% CI 0.97-4.13) and (2.14; 95% CI 1.11-4.13).
This study could not confirm an adverse association between DM or its control during treatment and the course of response to TB treatment.DM screening in TB cases and recording of DM care needs to be improved to enable more conclusive evidence.
印度喀拉拉邦报告称结核病(TB)和糖尿病(DM)的双重负担最大。喀拉拉邦的马拉普兰区自 2010 年以来一直在修订国家结核病控制规划(RNTCP)下监测和记录 DM 状况及其控制情况。
在规划条件下评估记录结核病病例中 DM 状况的全面性以及 DM 患者(按血糖控制情况分类)的结核病治疗结局,并与非 DM 患者进行比较。
本回顾性病历审查包括 2010 年 4 月至 2011 年 9 月期间的 3116 例结核病患者。DM 按照国际指南定义,结核病治疗结局分为有利(治愈和治疗完成)和不利(死亡、失访、失败和转出)。计算相对风险(RR)和 95%置信区间(CI)以评估不利结局的风险。
90%的结核病病例记录了 DM 状况,667 例(24%)患有 DM。17%的 DM 患者和 23%的 DM 状况未知的患者出现不良结局,但差异无统计学意义。未经调整的 RR 为不良血糖控制或未知控制状态与不良结局相关的比值比为(2.00;95%CI 0.97-4.13)和(2.14;95%CI 1.11-4.13)。
本研究不能证实 DM 或其在治疗期间的控制与结核病治疗反应的过程之间存在不良关联。需要改进结核病病例中的 DM 筛查和 DM 护理记录,以提供更具结论性的证据。